Equifax Toekomstige groei
Future criteriumcontroles 5/6
Equifax zal naar verwachting groeien in winst en omzet met respectievelijk 26.8% en 10.8% per jaar. De winst per aandeel zal naar verwachting groeien met 26.8% per jaar. Het rendement op het eigen vermogen zal over 3 jaar naar verwachting 21.2% zijn.
Belangrijke informatie
26.8%
Groei van de winst
26.8%
Groei van de winst per aandeel
Professional Services winstgroei | 15.6% |
Inkomstengroei | 10.8% |
Toekomstig rendement op eigen vermogen | 21.2% |
Dekking van analisten | Good |
Laatst bijgewerkt | 04 Nov 2024 |
Recente toekomstige groei-updates
Recent updates
Equifax (NYSE:EFX) Is Looking To Continue Growing Its Returns On Capital
Nov 05Equifax: Stay Buy Rated As Medium-Term Growth Outlook Remains Positive
Oct 22At US$284, Is Equifax Inc. (NYSE:EFX) Worth Looking At Closely?
Oct 06Is Equifax Inc. (NYSE:EFX) Trading At A 39% Discount?
Sep 20Why We're Not Concerned About Equifax Inc.'s (NYSE:EFX) Share Price
Sep 05Equifax: A Potential Beneficiary Of Interest Rate Cut
Sep 02US$290 - That's What Analysts Think Equifax Inc. (NYSE:EFX) Is Worth After These Results
Jul 25Equifax Earnings Preview: Growth Numbers Do Not Support Its Price
Jul 09Why Equifax Inc. (NYSE:EFX) Could Be Worth Watching
May 25Equifax Earnings: Underwhelming Performance, Not Worth The Investment
Apr 18A Look At The Intrinsic Value Of Equifax Inc. (NYSE:EFX)
Apr 12Equifax Q1 Preview: Mortgage Business Normalization And Non-Mortgage Growth (Rating Upgrade)
Apr 09Investors Appear Satisfied With Equifax Inc.'s (NYSE:EFX) Prospects
Mar 28These 4 Measures Indicate That Equifax (NYSE:EFX) Is Using Debt Extensively
Mar 12At US$257, Is It Time To Put Equifax Inc. (NYSE:EFX) On Your Watch List?
Feb 22Equifax: Well-Positioned For A Rebound Of The Mortgage Market
Jan 26Equifax (NYSE:EFX) Hasn't Managed To Accelerate Its Returns
Jan 23Equifax: Great Time To Sell At This Price, As Tepid Mortgage Demand Weighs On Earnings
Jan 04Why Investors Shouldn't Be Surprised By Equifax Inc.'s (NYSE:EFX) P/E
Dec 24Estimating The Intrinsic Value Of Equifax Inc. (NYSE:EFX)
Dec 08Equifax (NYSE:EFX) Has A Somewhat Strained Balance Sheet
Nov 23Returns At Equifax (NYSE:EFX) Appear To Be Weighed Down
Oct 23Equifax: Guidance Revised But Uncertainty Remains
Oct 22Equifax: Lowered FY23 Guidance, But Q423 EPS Ramp-Up Is Still Steep
Sep 06At US$207, Is It Time To Put Equifax Inc. (NYSE:EFX) On Your Watch List?
Sep 02Equifax (NYSE:EFX) Takes On Some Risk With Its Use Of Debt
Aug 15Equifax: Credit Bureau Giant Turning The Tide Of Adversity
Jul 21A Look At The Intrinsic Value Of Equifax Inc. (NYSE:EFX)
Jul 16Capital Allocation Trends At Equifax (NYSE:EFX) Aren't Ideal
Jun 30Is It Time To Consider Buying Equifax Inc. (NYSE:EFX)?
May 31Does Equifax (NYSE:EFX) Have A Healthy Balance Sheet?
May 16Are Investors Undervaluing Equifax Inc. (NYSE:EFX) By 34%?
Apr 10Equifax's (NYSE:EFX) Returns Have Hit A Wall
Mar 27Winst- en omzetgroeiprognoses
Datum | Inkomsten | Inkomsten | Vrije kasstroom | Geldmiddelen uit operationele activiteiten | Gem. Aantal analisten |
---|---|---|---|---|---|
12/31/2026 | 7,169 | 1,207 | 1,553 | 2,069 | 18 |
12/31/2025 | 6,387 | 963 | 1,214 | 1,679 | 20 |
12/31/2024 | 5,709 | 648 | 877 | 1,288 | 20 |
9/30/2024 | 5,588 | 563 | 784 | 1,322 | N/A |
6/30/2024 | 5,466 | 583 | 675 | 1,224 | N/A |
3/31/2024 | 5,353 | 558 | 644 | 1,219 | N/A |
12/31/2023 | 5,265 | 545 | 516 | 1,117 | N/A |
9/30/2023 | 5,137 | 521 | 508 | 1,120 | N/A |
6/30/2023 | 5,062 | 524 | 463 | 1,093 | N/A |
3/31/2023 | 5,061 | 587 | 480 | 1,107 | N/A |
12/31/2022 | 5,122 | 696 | 133 | 757 | N/A |
9/30/2022 | 5,178 | 710 | 213 | 817 | N/A |
6/30/2022 | 5,156 | 750 | 312 | 861 | N/A |
3/31/2022 | 5,074 | 764 | 480 | 993 | N/A |
12/31/2021 | 4,924 | 744 | 866 | 1,335 | N/A |
9/30/2021 | 4,789 | 697 | 802 | 1,247 | N/A |
6/30/2021 | 4,635 | 720 | 751 | 1,215 | N/A |
3/31/2021 | 4,383 | 605 | 613 | 1,059 | N/A |
12/31/2020 | 4,128 | 520 | 525 | 946 | N/A |
9/30/2020 | 3,915 | 470 | 476 | 880 | N/A |
6/30/2020 | 3,722 | 322 | -36 | 348 | N/A |
3/31/2020 | 3,619 | 289 | -59 | 314 | N/A |
12/31/2019 | 3,508 | -384 | -86 | 314 | N/A |
9/30/2019 | 3,437 | -382 | -172 | 248 | N/A |
6/30/2019 | 3,396 | -425 | 154 | 565 | N/A |
3/31/2019 | 3,393 | -347 | 203 | 584 | N/A |
12/31/2018 | 3,412 | 311 | 350 | 672 | N/A |
9/30/2018 | 3,415 | 447 | 446 | 715 | N/A |
6/30/2018 | 3,416 | 504 | N/A | 842 | N/A |
3/31/2018 | 3,396 | 525 | N/A | 832 | N/A |
12/31/2017 | 3,362 | 587 | N/A | 816 | N/A |
9/30/2017 | 3,325 | 538 | N/A | 888 | N/A |
6/30/2017 | 3,294 | 575 | N/A | 854 | N/A |
3/31/2017 | 3,249 | 540 | N/A | 819 | N/A |
12/31/2016 | 3,145 | 489 | N/A | 823 | N/A |
9/30/2016 | 3,010 | 478 | N/A | 750 | N/A |
6/30/2016 | 2,873 | 463 | N/A | 751 | N/A |
3/31/2016 | 2,740 | 443 | N/A | 747 | N/A |
12/31/2015 | 2,664 | 429 | N/A | 769 | N/A |
9/30/2015 | 2,622 | 415 | N/A | 740 | N/A |
6/30/2015 | 2,568 | 390 | N/A | 681 | N/A |
3/31/2015 | 2,504 | 372 | N/A | 647 | N/A |
12/31/2014 | 2,436 | 367 | N/A | 616 | N/A |
9/30/2014 | 2,390 | 346 | N/A | 605 | N/A |
6/30/2014 | 2,349 | 338 | N/A | 591 | N/A |
3/31/2014 | 2,322 | 335 | N/A | 575 | N/A |
12/31/2013 | 2,304 | 333 | N/A | 569 | N/A |
Toekomstige groeivoorspellingen analisten
Verdiensten versus spaarpercentage: De verwachte winstgroei EFX ( 26.8% per jaar) ligt boven de spaarquote ( 2.5% ).
Winst versus markt: De winst van EFX ( 26.8% per jaar) zal naar verwachting sneller groeien dan de US markt ( 15.2% per jaar).
Hoge groeiwinsten: De winst van EFX zal naar verwachting de komende 3 jaar aanzienlijk groeien.
Omzet versus markt: De omzet van EFX ( 10.8% per jaar) zal naar verwachting sneller groeien dan de markt US ( 8.8% per jaar).
Hoge groei-inkomsten: De omzet van EFX ( 10.8% per jaar) zal naar verwachting langzamer groeien dan 20% per jaar.
Groeiprognoses winst per aandeel
Toekomstig rendement op eigen vermogen
Toekomstige ROE: Het rendement op eigen vermogen EFX zal naar verwachting over 3 jaar hoog zijn ( 21.2 %)